Sam Chun Dang Pharm. Co., Ltd (000250.KQ) stock analysis

In our weekly check, Sam Chun Dang Pharm. Co., Ltd is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 5, red flags: 6.

About Sam Chun Dang Pharm. Co., Ltd

Sam Chun Dang Pharm. Co., Ltd is a Healthcare company (Medical - Pharmaceuticals) based in South Korea, listed on KOE as 000250.KQ.

What our checks show for 000250.KQ

Red flags

• Analysts expect revenue to shrink about 12.4% a year.
• Free cash flow is negative (-16.5% of revenue): the business spends more cash than it brings in.
• The price swings a lot: 116% annual volatility. Expect large ups and downs.
• The stock has fallen as much as 89% from a peak. Would you have held through that?
• Return on capital (ROCE) is only 3.7%.
• Pay in shares equals 0% of free cash flow: it dilutes shareholders.

Warning signs

• The gross margin fell by 2.4 points, to 46.1%: costs are rising faster than prices.
• Analysts expect earnings per share to shrink about 1.3% a year.
• The net margin is only 6.8%: little room if costs rise.
• The stock is still below its previous peak.
• Thinly traded (about 142 thousand shares a day): buying and selling can move the price.

Strengths

• Debt is low: 0.17x equity.
• Operating profit covers interest 15.4 times over.
• The net margin rose by 16.7 points over 5 years, to 6.8%.
• Operating cash flow is 1.47x net profit: the profit arrives as real cash.
• Analysts expect the net margin to improve by 2.5 points from today's 6.8%.
• Earnings per share grew 42.3% a year over the last 3 years.

Next earnings report: 2026-11-12

Similar companies

RICHT.BD · 4151.T

Questions

What grade does Sam Chun Dang Pharm. Co., Ltd (000250.KQ) have?

In our weekly check, Sam Chun Dang Pharm. Co., Ltd is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 14 pass, warnings: 5, red flags: 6. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of 000250.KQ stock?

This week's biggest flags for Sam Chun Dang Pharm. Co., Ltd: Weak revenue forecast, Weak free cash flow, Very volatile. In total 11 of 25 checks show a warning or a red flag.

What does Sam Chun Dang Pharm. Co., Ltd do?

Sam Chun Dang Pharm. Co., Ltd is a Healthcare company (Medical - Pharmaceuticals) based in South Korea, listed on KOE as 000250.KQ.

When does Sam Chun Dang Pharm. Co., Ltd report earnings next?

The next earnings report is expected on 2026-11-12. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-10-31

Open the full analysis